CISNE versus MASCC: Identifying low risk febrile neutropenic patients

被引:9
|
作者
Mohindra, Ritin [1 ,2 ]
Mathew, Roshan [2 ]
Yadav, Sakshi [2 ]
Aggarwal, Praveen [2 ]
机构
[1] PGIMER, Dept Internal Med, Chandigarh, India
[2] All India Inst Med Sci, Dept Emergency Med, New Delhi, India
来源
关键词
Febrile neutropenia; MASCC; CISNE; Chemotherapy; Emergency department; INFECTIOUS-DISEASES SOCIETY; CLINICAL-PRACTICE GUIDELINE; OUTPATIENT MANAGEMENT; MULTINATIONAL-ASSOCIATION; SUPPORTIVE-CARE; INDEX; SCORES;
D O I
10.1016/j.ajem.2019.09.016
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Febrile neutropenia though a dreaded complication of chemotherapy, not all patients need inpatient treatment. Risk score indices like MASCC and CISNE have been developed to identify low risk patients eligible for outpatient management. We undertook this study to compare the performances of MASCC and CISNE. Methods: This was a prospective observational study conducted in a tertiary care centre from August 2017 to April 2019 where patients with chemotherapy induced febrile neutropenia were included. Basic demographic data and primary site of cancer were collected with characteristics required to calculate both MASCC and CISNE scores. The primary outcome measure was 30-day mortality. Apart from the 3 group risk stratification of CISNE, apriori it was decided that two-tier CISNE score will be calculated with 0 or 1 score as low risk and >= 2 as high risk. Descriptive statistics are reported and predictive performance of each score was analysed. Results: Total of 129 patients were recruited. The performance of three-tier CISNE score was more specific (90.6%, 95% CI 76.9-96.9) but sensitivity (25.1%, 95% CI 17.0-36.3) was low compared to that of MASCC score (sensitivity 58.1%, 95% CI 47.0-68.5; specificity 65.1, 95% CI 49.0-78.5%). However, analysis with two-tier CISNE score demonstrated a better sensitivity (56.9%, 95%CI 45.8-67.4). Kappa for agreement between the two scores was 0.520 (95% CI 0.373-0.667, p < 0.001). Conclusion: CISNE and MASCC have fair discriminatory power in identifying low risk febrile neutropenia cases. Two group stratification on CISNE scoring will help in better decision making in emergency department. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:2259 / 2263
页数:5
相关论文
共 50 条
  • [1] Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk Febrile Neutropenic Patients in the Emergency Department
    Coyne, Christopher J.
    Le, Vivian
    Brennan, Jesse J.
    Castillo, Edward M.
    Shatsky, Rebecca A.
    Ferran, Karen
    Brodine, Stephanie
    Vilke, Gary M.
    [J]. ANNALS OF EMERGENCY MEDICINE, 2017, 69 (06) : 755 - 764
  • [2] Performance of a modified MASCC index score for identifying low-risk febrile neutropenic cancer patients
    Luciano de Souza Viana
    José Carlos Serufo
    Manoel Otávio da Costa Rocha
    Renato Nogueira Costa
    Roberto Carlos Duarte
    [J]. Supportive Care in Cancer, 2008, 16 : 841 - 846
  • [3] Performance of a modified MASCC index score for identifying low-risk febrile neutropenic cancer patients
    Viana, Luciano de Souza
    Serufo, Jose Carlos
    da Costa Rocha, Manoel Otavio
    Costa, Renato Nogueira
    Duarte, Roberto Carlos
    [J]. SUPPORTIVE CARE IN CANCER, 2008, 16 (07) : 841 - 846
  • [4] Performance of MASCC score and other factors for identifying low-risk febrile-neutropenic cancer patients
    Bajpal, J.
    Prabhash, K.
    Medhekar, A.
    Nair, R.
    Kurkure, P.
    Ghadyalpatil, N.
    Gupta, S.
    Noronha, V.
    Kudale, P. D.
    Banavali, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Assessment and comparison of CISNE model versus MASCC model in clinically stable febrile neutropenia patients
    Koppaka, D.
    Kuntegowdanahalli, L. C.
    Lokanath, D.
    Babu, K. Govind
    Jacob, L. A.
    Babu, M. C. Suresh
    Lokesh, K. N.
    Rudresha, A. H.
    Rajeev, L. K.
    Smitha, S. C.
    Anand, A.
    Asati, V.
    Chethan, R.
    Patidar, R.
    Chaudhuri, T.
    Kasturi, A.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 129 - 129
  • [6] Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter?
    Marianne Paesmans
    Jean Klastersky
    Johan Maertens
    Aspasia Georgala
    Frédérique Muanza
    Mickael Aoun
    Augustin Ferrant
    Bernardo Rapoport
    Ken Rolston
    Lieveke Ameye
    [J]. Supportive Care in Cancer, 2011, 19 : 1001 - 1008
  • [7] Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter?
    Paesmans, Marianne
    Klastersky, Jean
    Maertens, Johan
    Georgala, Aspasia
    Muanza, Frederique
    Aoun, Mickael
    Ferrant, Augustin
    Rapoport, Bernardo
    Rolston, Ken
    Ameye, Lieveke
    [J]. SUPPORTIVE CARE IN CANCER, 2011, 19 (07) : 1001 - 1008
  • [8] Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents
    Ahn, Shin
    Rice, Terry W.
    Yeung, Sai-ching J.
    Cooksley, Tim
    [J]. SUPPORTIVE CARE IN CANCER, 2018, 26 (05) : 1465 - 1470
  • [9] Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents
    Shin Ahn
    Terry W. Rice
    Sai-ching J. Yeung
    Tim Cooksley
    [J]. Supportive Care in Cancer, 2018, 26 : 1465 - 1470
  • [10] The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients
    Klastersky, Jean
    Paesmans, Marianne
    [J]. SUPPORTIVE CARE IN CANCER, 2013, 21 (05) : 1487 - 1495